Conferences

Early origins and mechanisms of chronic lung disease, Estoril 2013

The Lung Science Conference is at the forefront of basic and translational respiratory science and it is an essential event for budding respiratory researchers looking to boost their career.

Educational aims

To present the very best of international lung science research
To highlight new discoveries likely to impact on the future of respiratory medicine
To encourage debate and interaction between young postdoctoral scientists and established investigators

Download all media

Opening Lecture: Making translational research work: from bench to bedside and back again P. O'Byrne (Hamilton, Canada)
Presentation by an expert: Early influences of the airway microbiome on obstructive lung disease E. von Mutius (Munich, Germany)
Oral presentation: A comparative analysis of bacterial phylotypes of the lung microbiota of healthy, IPF and transplanted lungs J. Erb-Downward (Ann Arbor, United States of America)
Presentation by an expert: Emerging relationships between airway microbiota and chronic respiratory disease : mechanisms of disease onset G. Huffnagle (Ann Arbour, United States of America)
Oral presentation: The role of mast cells, IL-13 and TRP channels in a mouse model of chemical-induced airway hyperresponsiveness M. Harrison (Cork, Ireland)
Presentation by an expert: Epithelial barrier biology: interactions between the epithelium and lymphocytes in disease M. Veldhoen (Cambridge, United Kingdom)
Oral presentation: Identifying a molecular defect in bronchial epithelial cells from 70% of mild asthmatics S. Chowdhury (Amsterdam, Netherlands)
Oral presentation: Sphingosine-1-phosphate administration in vivo induces airway inflammation and hypereactivity in a IgE-dependent manner F. Roviezzo (Naples, Italy)
Oral presentation: Role of CXCL13 in cigarette smoke-induced lymphoid follicle formation and COPD K. Bracke (Laarne, Belgium)
Presentation by an expert: Early microbial exposures and persistent effects on immune function R. Blumberg (Boston, United States of America)
Oral presentation: The long-term effect of neonatal respiratory syncytial virus (RSV) infection on the response to adult allergen challenge L. Lambert (St. Paul, United States of America)
Oral presentation: NF-?? acts downstream of EGFR in regulating low dose cadmium induced primary lung cell proliferation A. Bhattacharyya (Kolkata, India)
Presentation by an expert: Modelling and remodelling: when does asthma begin? A. Bush (London, United Kingdom)
Oral presentation: An in vivo approach to determine the dynamic Sox2 interactome of the developing lung K. Schilders (Rotterdam, The Netherlands)
Oral presentation: Early sources of IL-13 in house dust mite-induced neonatal allergic airways disease J. Vasiliou (London, United Kingdom)
Young Investigator session: Overexpression of IRF5 ameliorates house dust mite-mediated airway hyper-responsiveness via macrophage polarisation towards a classically activated phenotype A. Byrne, (London, United Kingdom)
Young Investigator session: MicroRNA based biomarkers for early risk assessment of asthma K. Milger (Munich, Germany)
Young Investigator session: Mechanisms regulating enhanced ?v?6 expression in pulmonary fibrosis A. Tatler (Nottingham, United Kingdom)
Young Investigator session: Dietary fiber shapes the intestinal and airway microbiome, alters dendritic cell functionality, and leads to an environment less permissive to allergic inflammation. A. Trompette (Lausanne, Switzerland)
Young Investigator session: Perinatal antibiotic treatment affects murine microbiota, immune responses, and pathology in models of allergic asthma and hypersensitivity pneumonitis S. Russell (Vancouver, Canada)
Presentation by an expert: Innate lymphoid cells: Development, lineage and function J. Mjosberg (Amsterdam, Netherlands)
Oral presentation: The role of mast cells, IL-13 and TRP channels in a mouse model of chemical-induced airway hyperresponsiveness F. Devos (Leuven, Belgium)
Oral presentation: TLR-3 triggered aggravation of experimental asthma depends on IL-17 L. Lunding (Borstel , Germany)
Presentation by an expert: Interactions between innate immunity, inflammation and structural cells in pulmonary disease G. Downey (Denver, United States of America)
Presentation by an expert: IL33 and onset of chronic lung disease M. Wills-Karp (Baltimore, United States of America)
Presentation by an expert: IL17 and the development of inflammatory airway diseases J. Kolls (Pittsburgh, United States of America)
Poster Presentation - abstracts